Company Filing History:
Years Active: 2004
Title: Christoph Geserick: Innovator in Birth Control and Alzheimer's Treatment
Introduction
Christoph Geserick is a notable inventor based in Berlin, Germany. He has made significant contributions to the fields of reproductive health and neurodegenerative diseases. His innovative work focuses on the human PEM polypeptide, which plays a crucial role in sperm maturation and Alzheimer's disease.
Latest Patents
Geserick holds a patent for his invention titled "Human PEM as a target for birth control and treatment of Alzheimer's disease." This invention relates to the human PEM polypeptide and its potential applications in male birth control and the treatment of Alzheimer's disease. The patent outlines the use of PEM as a target in male contraception and for diagnosing and treating male infertility and Alzheimer's disease. It also includes a selection process for PEM antagonists and the production of binding molecules that specifically detect PEM. Additionally, the invention encompasses genes regulated by the PEM gene.
Career Highlights
Christoph Geserick is associated with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has garnered attention for its potential impact on both reproductive health and neurodegenerative disease treatment.
Collaborations
Geserick has collaborated with notable colleagues, including Bertram Weiss and Bernard Jacques Haendler. Their combined expertise has contributed to the advancement of research in their respective fields.
Conclusion
Christoph Geserick's innovative work in the realm of human PEM polypeptide has the potential to revolutionize male birth control and Alzheimer's disease treatment. His contributions reflect the importance of research and innovation in addressing significant health challenges.